- Home
- NXST vs CRSP Comparison
NXST vs CRSP Comparison
Compare NXST & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXST
- CRSP
- Stock Information
- Founded
- NXST 1996
- CRSP 2013
- Country
- NXST United States
- CRSP Switzerland
- Employees
- NXST N/A
- CRSP N/A
- Industry
- NXST Broadcasting
- CRSP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NXST Industrials
- CRSP Health Care
- Exchange
- NXST Nasdaq
- CRSP Nasdaq
- Market Cap
- NXST 6.3B
- CRSP 5.6B
- IPO Year
- NXST 2003
- CRSP 2016
- Fundamental
- Price
- NXST $189.72
- CRSP $53.65
- Analyst Decision
- NXST Strong Buy
- CRSP Buy
- Analyst Count
- NXST 7
- CRSP 18
- Target Price
- NXST $221.43
- CRSP $73.47
- AVG Volume (30 Days)
- NXST 278.5K
- CRSP 2.4M
- Earning Date
- NXST 11-06-2025
- CRSP 11-04-2025
- Dividend Yield
- NXST 3.93%
- CRSP N/A
- EPS Growth
- NXST N/A
- CRSP N/A
- EPS
- NXST 16.23
- CRSP N/A
- Revenue
- NXST $5,147,000,000.00
- CRSP $38,050,000.00
- Revenue This Year
- NXST N/A
- CRSP N/A
- Revenue Next Year
- NXST $10.27
- CRSP $391.94
- P/E Ratio
- NXST $11.67
- CRSP N/A
- Revenue Growth
- NXST N/A
- CRSP N/A
- 52 Week Low
- NXST $141.66
- CRSP $30.04
- 52 Week High
- NXST $223.36
- CRSP $78.48
- Technical
- Relative Strength Index (RSI)
- NXST 39.53
- CRSP 33.49
- Support Level
- NXST $181.54
- CRSP $64.80
- Resistance Level
- NXST $200.41
- CRSP $58.75
- Average True Range (ATR)
- NXST 5.56
- CRSP 3.37
- MACD
- NXST -0.07
- CRSP -1.67
- Stochastic Oscillator
- NXST 31.58
- CRSP 5.97
About NXST Nexstar Media Group Inc.
Nexstar is the largest television station owner-operator in the United States with over 200 stations in 116 markets, reaching 220 million people. Of its 200 stations, 155 are affiliated with the four national broadcast networks: CBS, Fox, NBC, and ABC. Pending approval, Nexstar's merger with Tegna would bring Nexstar's station total to 259 in 133 markets, reaching 80% of the US population. Nexstar also owns NewsNation (formerly WGN), a cable news network, 75% of the fifth national broadcaster, the CW, and a 31% stake in Food Network and Cooking Channel.
About CRSP CRISPR Therapeutics AG
Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.